Artificial Neural Network: An Accessible Itinerary in the Rational Development of Drug Design and Development
Abstract
Keywords
Full Text:
PDFReferences
McCulloch WS, Pitts W. A logical calculus of the ideas immanent in nervous activity. Bull Math Biophys. 1943;5:115–133. doi:10.1007/ BF02478259. (L. Gentiluomo, D. Roessner, D. Augustijn, H. Svilenov, A. Kulakova, S. Mahapatra, G. Winter, W. Streicher, a. Rinnan, G.H.J. Peters, P. Harris, W. Frieß, Application of interpretable artificial neural networks to early monoclonal antibodies development, European Journal of Pharmaceutics and Biopharmaceutics (2019)).
D.E. Heckerman, E.H. Shortliffe, Artificial Intelligence Med. 4 (1992) 35–52. H.B. Jimison, L.M. Fagan, R.D. Shachter, E.H. Shortliffe, Artificial Intelligence Med. 4 (1992) 191–205.
Rosenblatt F. The perceptron: a probabilistic model for information storage and organization in the brain. Psychol Rev. 1958;65(6):386–408.
Igor I. Baskin, David Winkler & Igor V. Tetko (2016) A renaissance of neural networks in drug discovery, Expert Opinion on Drug Discovery, 11:8, 785–795.
Aoyama T, Suzuki Y, Ichikawa H. Neural networks applied to structure-activity relationships. J Med Chem. 1990;33(3):905–908.
McCulloch WS, Pitts W. A logical calculus of the ideas immanent in nervous activity. Bull Math Biophys. 1943;5:115–133. doi:10.1007/ BF02478259.
Baskin II, Skvortsova MI, Stankevich IV, et al. On the basis of invariants of labeled molecular graphs. J Chem Inf Comput Sci.1995;35(3):527–531.
Artemenko NV, Baskin II, Palyulin VA, et al. Artificial neural network and fragmental approach in prediction of physicochemical properties of organic compounds. Russian Chem Bull. 2003;52(1):20–29.
Halberstam NM, Baskin II, Palyulin VA, et al. Neural networks as amethod for elucidating structure-property relationships for organic compounds. Russian Chem Rev. 2003;72(7):629–649.
Rumelhart DE, Hinton GE, Williams RJ. Learning internal representations by backpropagating errors. Nature. 1986;33:533–536.
Tetko IV, Livingstone DJ, Luik AI. Neural network studies. 1. Comparison of overfitting and overtraining. J Chem Inf Comput Sci. 1995;35(5):826–833.
Baskin II, Palyulin VA, Zefirov NS. Neural networks in building QSAR models. Methods Mol Biol (Clifton, NJ). 2008;458:137–158.
Varnek A, Gaudin C, Marcou G, et al. Inductive transfer of knowledge: application of multi-task learning and feature net approaches to model tissue-air partition coefficients. J Chem Inf Model. 2009;49 (1):133–144.
Caruana R. Multitask learning. Mach Learn. 1997;28(1):41–75.
Markou M, Singh S. Novelty detection: a review – part 2: neural network based approaches. Signal Process. 2003;83(12):2499–2521. doi:10.1016/j.sigpro.2003.07.019.
Karpov PV, Osolodkin DI, Baskin II, et al. One-class classification as a novel method of ligand-based virtual screening: the case of glycogen synthase kinase 3ОІ inhibitors. Bioorg Med Chem Lett. 2011;21 (22):6728–6731.
Tikhonov AN, Arsenin VY. Solutions of ill-posed problems. New York: Winston; 1977.
Burden F, Winkler D. Bayesian regularization of neural networks. Methods Mol Biol. 2008;458:25–44.
Burden FR, Ford MG, Whitley DC, et al. Use of automatic relevance determination in QSAR studies using Bayesian neural networks. J Chem Inf Comput Sci. 2000;40(6):1423–1430.
Burden FR, Winkler DA. Optimal sparse descriptor selection for QSAR using Bayesian methods. QSAR Comb Sci. 2009;28(6– 7):645–653.
Winkler DA, Burden FR. Bayesian neural nets for modeling in drug discovery. Drug Discovery Today BIOSILICO. 2004;2(3):104–111.
Bruneau P. Search for predictive generic model of aqueous solubility using Bayesian neural nets. J Chem Inf Comput Sci. 2001;41 (6):1605–1616.
Burden FR, Winkler DA. A quantitative structure-activity relationships model for the acute toxicity of substituted benzenes to Tetrahymena pyriformis using Bayesian-regularized neural networks. Chem Res Toxicol. 2000;13(6):436–440.
Epa VC, Burden FR, Tassa C, et al. Modeling biological activities of nanoparticles. Nano Lett. 2012;12(11):5808–5812.
Winkler DA, Mombelli E, Pietroiusti A, et al. Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential. Toxicol. 2013;313(1):15–23.
Kohonen T. Self-organizing maps. Berlin: Springer; 2001.
Anzali S, Gasteiger J, Holzgrabe U, et al. The use of self-organizing neural networks in drug design. Perspect Drug Discov Des. 1998;9:273–299.
Schneider P, Mueller AT, Gabernet G, et al. Hybrid network model for “deep learning” of chemical data: application to antimicrobial peptides. Mol Inform. 2016.
Refbacks
- There are currently no refbacks.